ICPT
Intercept Pharmaceuticals, Inc.
ICPT
ICPT
Delisted
ICPT was delisted on the 7th of November, 2023.
150 hedge funds and large institutions have $566M invested in Intercept Pharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 41 increasing their positions, 55 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
150
Holders Change
-24
Holders Change %
-13.79%
% of All Funds
2.64%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
41
Reduced
55
Closed
39
Calls
$24.8M
Puts
$31.9M
Net Calls
-$7.12M
Net Calls Change
+$4.67M
Top Buyers
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
$59.2M |
| 2 |
Citadel Advisors
Miami,
Florida
|
$16.9M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
$76.1M |
| 4 |
State Street
Boston,
Massachusetts
|
$65.4M |
| 5 |
SB
Samsara BioCapital
Palo Alto,
California
|
$14.8M |
Top Sellers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
$540K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
$66.2M |
| 3 |
Goldman Sachs
New York
|
$11.4M |
| 4 |
Renaissance Technologies
New York
|
$822K |
| 5 |
JPMorgan Chase & Co
New York
|
$22.3M |
